Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HOTH | AMGN | VRTX | REGN | BMY |
| Company | Hoth Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.1700 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 1.2200 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 1.1700 | 312.87 | 428.62 | 966.34 | 44.52 |
| Last | 1.2000 | 320.27 | 437.29 | 976.78 | 44.53 |
| Change | +0.0200 | +8.86 | +8.70 | -7.86 | -0.18 |
| % Change | +1.69% | +2.85% | +2.03% | -0.80% | -0.40% |
| Volume | 24,926 | 1,856,234 | 535,829 | 352,470 | 5,522,659 |
| 20-Day Average Volume | 24,792 | 2,884,579 | 1,079,807 | 451,617 | 14,014,113 |
| Previous Close | 1.1800 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1885 | 288.82 | 407.48 | 931.27 | 45.49 |
| 20-Day Raw Stochastic | 41.18% | 94.95% | 94.93% | 90.09% | 19.38% |
| 20-Day Relative Strength | 44.81% | 68.99% | 68.69% | 61.14% | 35.72% |
| Weighted Alpha | -48.10 | +43.14 | +29.72 | +30.01 | -33.21 |
| Today's Opinion | 100% Sell | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 48% Sell | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.31% since 05/08/24 | +3.96% since 05/08/24 | +4.30% since 05/08/24 | +2.29% since 05/08/24 | +1.99% since 05/08/24 |
| Low | 1.1600 on 05/10/24 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 1.2300 on 05/14/24 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -2.50% since 04/15/24 | +20.32% since 04/15/24 | +9.93% since 04/15/24 | +8.81% since 04/15/24 | -8.18% since 04/15/24 |
| Low | 1.1000 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.2700 on 05/03/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -17.34% since 02/15/24 | +10.52% since 02/15/24 | +2.47% since 02/15/24 | +2.40% since 02/15/24 | -9.91% since 02/15/24 |
| Low | 1.1000 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.6700 on 03/19/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +13.59% since 11/15/23 | +17.01% since 11/15/23 | +25.04% since 11/15/23 | +23.39% since 11/15/23 | -13.63% since 11/15/23 |
| Low | 1.0100 on 11/17/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 1.7300 on 12/27/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,769 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 4,889 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -7,850,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,700,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.65 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/13/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |